Related Experiment Video
Updated: Sep 5, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Age-associated differences in the cancer molecular landscape
Kasit Chatsirisupachai1, Cyril Lagger1, João Pedro de Magalhães1
1Integrative Genomics of Ageing Group, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L7 8TX, UK.
Cancer is an age-related disease. Molecular differences in tumors between younger and older patients, including genomic and epigenetic changes, are increasingly understood, informing personalized cancer medicine.
Area of Science:
- Oncology
- Aging Research
- Genomics
- Epigenetics
- Immunology
Background:
- Cancer incidence and mortality significantly increase with age, indicating a strong link between aging and cancer.
- Despite this, the molecular distinctions within tumors across different age groups are not well understood.
- Recent research is beginning to illuminate the age-associated molecular characteristics of cancer.
Purpose of the Study:
- To summarize current findings on age-related molecular differences in cancer.
- To highlight variations in genomic, transcriptomic, epigenetic, and immunological landscapes between cancers in younger and older individuals.
- To discuss the influence of aging processes on these observed cancer disparities.
Main Methods:
- Review and synthesis of recent studies on age-associated cancer molecular landscapes.
- Comparative analysis of genomic, transcriptomic, epigenetic, and immunological data from younger and older cancer patient cohorts.
- Exploration of aging-related biological processes potentially driving cancer differences.
Main Results:
- Significant differences exist in the genomic, transcriptomic, epigenetic, and immunological profiles of cancers in younger versus older patients.
- Specific cancer driver genes show differential mutation frequencies based on patient age.
- Aging processes are implicated as potential factors shaping these age-related molecular variations in cancer.
Conclusions:
- Understanding age-specific molecular alterations in cancer is crucial for advancing personalized medicine.
- Further research into unsolved questions regarding age-related cancer differences can yield significant clinical insights.
- Tailoring cancer treatments based on patient age and associated molecular profiles holds promise for improved outcomes.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

